Filing Details
- Accession Number:
- 0001062993-22-008073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-17 17:33:08
- Reporting Period:
- 2022-03-15
- Accepted Time:
- 2022-03-17 17:33:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1588972 | Recro Pharma Inc. | REPH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1201526 | Jr David J Enloe | C/O Recro Pharma, Inc. 1 E. Uwchlan Ave, Suite 112 Exton PA 19341 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-03-15 | 512 | $1.96 | 524,879 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
Billionaire Hedge Funds
